New onset atrial fibrillation after initiating amphetamine-dextroamphetamine therapy for ADHD: A case report

Aimee Wehber, Jeffrey Hirsh


Atrial fibrillation is a common arrhythmia in the general population, and is expected to significantly increase in prevalencein the near future. This case illustrates a 50-year-old male who developed atrial fibrillation after starting amphetaminedextroamphetaminefor attention deficit hyperactivity disorder (ADHD), with no previous history of structural heart disease. Central nervous system stimulant medications have significant cardiovascular implications and at risk patients should be monitoredclosely. Additionally, identifying causative agents for atrial fibrillation and other arrhythmias is imperative, as there is a significantassociation with morbidity and mortality.

Full Text:




  • There are currently no refbacks.

Case Reports in Internal Medicine

ISSN 2332-7243(Print)  ISSN 2332-7251(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the ‘’ domains to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', please check your 'spam' or 'junk' folder.